HomeDilutionPromotionUplist RadarBuzzToday on EDGARDead Stock Check
PubCo Insight › Tickers › CARM

$CARMNASDAQ NMS - GLOBAL MARKET

Carisma Therapeutics Inc.
Biotechnology
Market Cap
$21K
Exchange
NASDAQ NMS - GLOBAL MARKET
Filings (365d)
0
News (14d)
0
CIK
0001485003
Website
Company site ↗
SEC Filing Timeline
No material filings in our 365-day window.
Recent News (Finnhub)
No aggregated news in the last 14 days.
Source-linked from SEC EDGAR + Finnhub aggregated news.
Not investment advice. Always verify on SEC.gov directly.
Investor relations · CARM
Is this how AI describes Carisma Therapeutics Inc.?
This page is the public, source-linked snapshot that investors, brokers, and AI assistants pull for CARM: EDGAR filings and recent news, no editor, no spin. When an AI engine or a financial terminal shows stale, misclassified, or missing data for your ticker, that is the first thing investors see. Pulse IR runs a free 24-hour audit of how ChatGPT, Perplexity, Google, and the major terminals currently represent CARM, and can correct it.
Get the free AI visibility audit
For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.
PubCo Insight

See the dilution and promotion flags before you see the pitch.

Each week: the micro and small-caps now showing dilution or paid-promotion signals, with the SEC filing behind every flag. No recommendations, no price targets.

Every flag links to its EDGAR filing so you can check it yourself. Sponsored coverage disclosed under SEC 17(b). One-click unsubscribe.